ArticleJournal of Cancer2020

Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42.

Lingyu Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.